TMO - Thermo Fisher Scientific, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.
IPO Date: January 2, 1990
Sector: Healthcare
Industry: Life Sciences Tools and Services
Market Cap: $244.79B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.46 | 1.09%
Avg Daily Range (30 D): $7.74 | 1.21%
Avg Daily Range (90 D): $7.36 | 1.31%
Institutional Daily Volume
Avg Daily Volume: 1.83M
Avg Daily Volume (30 D): 1.62M
Avg Daily Volume (90 D): 1.6M
Trade Size
Avg Trade Size (Sh.): 87
Avg Trade Size (Sh.) (30 D): 29
Avg Trade Size (Sh.) (90 D): 28
Institutional Trades
Total Institutional Trades: 40,244
Avg Institutional Trade: $12.17M
Avg Institutional Trade (30 D): $52.23M
Avg Institutional Trade (90 D): $47.98M
Avg Institutional Trade Volume: .05M
Avg Institutional Trades (Per Day): 7
Market Closing Trades
Avg Closing Trade: $58.54M
Avg Closing Trade (30 D): $223.93M
Avg Closing Trade (90 D): $212.06M
Avg Closing Volume: 174.22K
 
News
Oct 7, 2026 @ 12:45 PM
Is This the Right Time to Add TMO Stock to Your Po...
Source: Na
Oct 6, 2026 @ 10:00 AM
Quantum BioPharma Signs Contract with Thermo Fishe...
Source: Na
Oct 6, 2026 @ 8:54 AM
Global Microfluidics Market by Product Type, Appli...
Source: Researchandmarkets.Com
Oct 6, 2026 @ 4:52 AM
Zacks Industry Outlook Globus Medical, Intuitive S...
Source: Zacks Investment Research
Oct 5, 2026 @ 11:09 AM
Beat the Market Like Zacks: Thermo Fisher, Cricut,...
Source: Na
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $18.62 $4.68 $4.44
Diluted EPS $18.59 $4.68 $4.43
Revenue $46.34B $11.99B $11.01B
Gross Profit
Net Income / Loss $6.99B $1.74B $1.66B
Operating Income / Loss $8.15B $2.09B $1.86B
Cost of Revenue
Net Cash Flow $-600M $718M $-6676M
PE Ratio